Cargando…
Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease
Venetoclax is a promising new drug for relapsed or refractory chronic lymphocytic leukemia (CLL). However, venetoclax use had not been reported in severe chronic kidney disease (CKD) patients. We report the first case of relapsed CLL in a severe CKD patient that was successfully treated with venetoc...
Autores principales: | Sugiura, Hiroyuki, Sezaki, Nobuo, Ishikawa, Tatsunori, Kuroi, Taiga, Okamoto, Sachiyo, Nomura, Naho, Masunari, Taro, Nakasako, Yukio, Kiguchi, Toru, Tanimoto, Mitsune |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010727/ https://www.ncbi.nlm.nih.gov/pubmed/35441018 http://dx.doi.org/10.1002/ccr3.5735 |
Ejemplares similares
-
Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations
por: Daido, Yusuke, et al.
Publicado: (2023) -
Concurrent Onset of Chronic Lymphocytic Leukemia and Atypical Phenotype Acute Myeloid Leukemia Revealed by Autopsy
por: Kiso, Sayaka, et al.
Publicado: (2021) -
A case of reversible cerebral vasoconstriction syndrome developing during treatment of adult aplastic anemia
por: Yamamoto, Akira, et al.
Publicado: (2018) -
A case report of TAFRO syndrome successfully treated by immunosuppressive therapies with plasma exchange
por: Meguri, Yusuke, et al.
Publicado: (2018) -
Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax
por: Izutsu, Koji, et al.
Publicado: (2023)